ATROLIP, created in 2000 (Czech Republic), from 2757 sister brands and 17477 competing brands. ATROLIP is owned by Sanofi, listed on the stock exchange of Paris Its International Securities Identification Number (ISIN) is FR0000120578. ATROLIP is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Sanofi
(ATROLIP)
over 5 years*
EUR 107.32